An international diagnostic services provider is setting up a clinical laboratory in Myanmar for the first time. Healthcare Nova talks to Dr. Win Zaw Aung, managing director of Sea Lion Group - investor in the BDMS-owned new new lab.
Indian diagnostics chain Metropolis has acquired Sanjeevani Pathology Labs in Rajkot, Gujarat, in an all-cash transaction. HBI speaks to Metropolis managing director Ameera Shah to find out more about the reasons behind the deal which concluded earlier this month, and the group's business strategy.
Large Polish lab group Diagnostyka is going to be put up for sale, as private equity player Mid Europa Partners looks to cash in again following on from its successful sale of Alpha Medical. Healthcare Europa catches up with Mid Europa co-managing partner Matthew Strassberg at a time when M&A activity has "rejuvenated" the market.
A strong performance in Europe - especially Germany and Switzerland - couldn't mask disappointing overall half-year results for Australian diagnostics network Sonic Healthcare, and its share price fell as the results were released on Monday.
In the past two months, SYNLAB, Cerba, Alliance Medical and LifeBrain, four major diagnostic service providers, have strengthened their presence in Italy through the acquisitions of small laboratory/imaging networks. But what is so attractive about Italy?
European laboratory services providers SYNLAB and Cerba are strengthening their position in Italy through the acquisitions of two medical centres networks in the north, in a race to become the main consolidator in the region.
Sanjeev Vashishta, former CEO of SRL, the largest international diagnostic group in India, speaks to us about his plans to build a new lab network, Path Kind, backed by Mankind Pharma Group, which he claims is India’s fourth largest pharmaceutical group.
Romanian healthcare services provider MedLife is buying Bucharest operator Anima, a group of six clinics providing outpatient services to public, private and corporate patients. We speak to Anima’s CEO Cristian Sas.
UK Prime Minister Theresa May has refused to rule out US corporations having a greater role to play in British healthcare, ahead of her meeting with US president Donald Trump today (Friday, January
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.